SC
RGLS

Steven Cohen’s Regulus Therapeutics RGLS Stock Holding History

Steven Cohen’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,968,293
Closed -$3.44M – 2540
2025
Q1 		$3.44M Buy
1,968,293
+1,073,165
+120% +$1.42M 0.01% 1073
2024
Q4 		$1.41M Buy
895,128
+1,366
+0.2% +$2.1K ﹤0.01% 1375
2024
Q3 		$1.4M Buy
+893,762
New +$1.48M ﹤0.01% 1307
2021
Q2 		– Sell
-321,544
Closed -$5.02M – 1138
2021
Q1 		$5.02M Hold
321,544
– – 0.02% 567
2020
Q4 		$4.29M Buy
+321,544
New +$2.36M 0.02% 608
2018
Q3 		– Sell
-6,150
Closed -$486K – 1191
2018
Q2 		$486K Hold
6,150
– – ﹤0.01% 871
2018
Q1 		$530K Sell
6,150
-3,357
-35% -$449K ﹤0.01% 849
2017
Q4 		$1.19M Buy
+9,507
New +$1.2M 0.01% 785

Other funds holding RGLS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Steven Cohen's RGLS Position: Q2 2025 in Review

Steven Cohen sold out of Regulus Therapeutics (RGLS) in Q2 2025, closing a stake of 1,968,293 shares — an estimated $3.44M sold.

Steven Cohen first reported a position in RGLS in Q4 2017 and held it in 8 quarters. The position peaked at $5.02M in Q1 2021. 0 funds tracked by Wall St. Rank hold RGLS as of Q2 2025.

  • Steven Cohen reported no remaining Regulus Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Steven Cohen sold 1,968,293 Regulus Therapeutics shares in Q2 2025, an estimated $3.44M.
  • Steven Cohen first reported a position in Regulus Therapeutics in Q4 2017 and held it in 8 quarters.
  • Steven Cohen's Regulus Therapeutics position peaked at $5.02M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q2 2025.

Based on Point72 Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.